老年患者修正或转换代谢减重手术的短期安全性与疗效:MBSAQIP 数据库分析
基于 MBSAQIP 2020–2024 数据库的回顾性比较分析,纳入 118,208 例修正/转换代谢减重手术,其中 8,042 例(6.8%)为 >65 岁老年患者。调整协变量后,老年患者 30 天主要并发症、吻合口或钉线漏及再手术的 odds 均显著高于 18–65 岁年轻患者,手术时间和住院时间更长,30 天 BMI 变化更小。
要点
- 老年患者修正/转换减重手术后 30 天主要并发症 adjusted OR 1.21(95%CI 1.11–1.32)。
- 吻合口或钉线漏 adjusted OR 1.68(95%CI 1.31–2.13),再手术 adjusted OR 1.17(95%CI 1.02–1.33)。
- >65 岁行修正/转换减重手术需仔细评估患者因素并加强围术期监测。
核心结论
- 基于 MBSAQIP 数据,与年轻成人相比,>65 岁患者行修正/转换代谢减重手术的 30 天 morbidity 风险显著更高。
研究设计与样本
- 回顾性比较分析,使用 2020–2024 年 MBSAQIP 数据库,比较 18–65 岁与 >65 岁患者修正/转换代谢减重手术的术后结局。
- 共纳入 118,208 例修正/转换代谢减重手术,其中 8,042 例(6.8%)为 >65 岁老年组。
- 主要结局为 30 天主要并发症发生率,定义为 Clavien-Dindo ≥2 级。
主要发现
- 老年组基线 BMI 更低、男性比例更高、合并症发生率更高。
- 调整患者和手术层面协变量后,老年组主要并发症 adjusted OR 1.21(95%CI 1.11–1.32),p<0.0001。
- 老年组吻合口或钉线漏 adjusted OR 1.68(95%CI 1.31–2.13),p<0.0001;再手术 adjusted OR 1.17(95%CI 1.02–1.33),p=0.026。
- 老年组平均手术时间延长 12.05 分钟(95%CI 10.48–13.62),住院时间延长 0.32 天(95%CI 0.27–0.37),30 天 BMI 变化低 0.1 kg/m2(95%CI 0.04–0.15)。
- 两组 30 天再干预或再入院 odds 无差异。
临床怎么用
- 对 >65 岁患者提供修正/转换代谢减重手术时,应仔细考虑患者因素并加强围术期监测以优化术后结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A subset of older adults who undergo metabolic and bariatric surgery (MBS) eventually requires revision or conversion of their index MBS procedure. However, the relative safety of revision/conversion MBS in the older population as compared to younger adults is unclear. METHODS: We conducted a retrospective comparative analysis of postoperative outcomes of revision/conversion MBS in patients 18-65 years of age (Younger) versus > 65 years of age (Older) using the 2020-2024 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database. Our primary outcome was 30-day incidence of major complications, defined as Clavien-Dindo Grade ≥ 2. RESULTS: From a total of 118,208 revision/conversion MBS procedures, 8042 (6.8%) were in the Older age group. Older patients had a lower BMI, were more likely to be male, and had a greater incidence of comorbid medical conditions at baseline compared to younger patients. After adjusting for patient and procedure-level covariates, older patients had a significantly greater odds of major complications (adjusted OR 1.21 [95% CI 1.11-1.32], p < 0.0001), anastomotic or staple line leak (adjusted OR 1.68 [95% CI 1.31-2.13], p < 0.0001), and reoperation (adjusted OR 1.17 [95% CI 1.02-1.33], p = 0.026). Older patients also had a longer average operative time (Mean Difference (MD) 12.05 min [95% CI 10.48-13.62], p < 0.0001), length of hospital stay (MD 0.32 days [95% CI 0.27-0.37], p < 0.0001), and a lower change in BMI at 30 days (MD 0.1 kg/m2 lower change in BMI [95% CI 0.04-0.15], p = 0.0003). There were no differences between the two age groups in odds of re-intervention or readmission at 30 days. CONCLUSION: Based on MBSAQIP data, revision/conversion MBS is associated with a significantly greater risk of morbidity in older patients as compared to younger adults. These findings suggest that revision/conversion MBS should be offered in the > 65 age group with careful consideration of patient factors and closer perioperative monitoring to optimize postoperative outcomes.
引用
- Brar K, Seymour KA, Sudan R, et al. Short-term safety and efficacy of revision or conversion metabolic and bariatric surgery in older adults: an analysis of the MBSAQIP database. Surg Endosc. 2026. PMID: 42432237. doi:10.1007/s00464-026-13033-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。